Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Silvio E Inzucchi

1-50 of 174 results

View this query on the Wikidata Query Service
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

scientific article
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

scientific article published on 14 June 2016
Oral antihyperglycemic therapy for type 2 diabetes: scientific review

scientific article
How do we define cure of diabetes?

scientific article published on November 2009
The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

scientific article
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

scientific article (publication date: May 2002)
Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

scientific article published in August 2004
Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial

scientific article
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

scientific article
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

scientific article published on 17 February 2016
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

scientific article published on 19 September 2019
Metformin in patients with type 2 diabetes and kidney disease: a systematic review

scientific article published on December 2014
Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

scientific article published on 6 June 2005
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

scientific article published in February 2005
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk

scientific article published on 11 February 2008
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

scientific article published on January 14, 2015
Use of metformin in the setting of mild-to-moderate renal insufficiency

scientific article
The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

scientific article
National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.

scientific article
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

scientific article
Metformin: new understandings, new uses

scientific article (publication date: 2003)
Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction

scientific article published in April 2009
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

scientific article
Aspirin for primary prevention of cardiovascular events in people with diabetes, etc.

scientific article
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 4 December 2017
HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study

scientific article published on 30 July 2013
New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

scientific article published on January 2008
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

scientific article published on June 2013
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.

scientific article
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

scientific article
Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes

scientific article published on August 19, 2010
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

scientific article
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

scientific article published on 13 September 2017
Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study

scientific article (publication date: November 2007)
Elevated admission glucose and mortality in elderly patients hospitalized with heart failure

scientific article published on 30 March 2009
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

scientific article published on February 1, 2018
Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action

scientific article published on July 1, 2013
New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications

scientific article published on January 2008
Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes

scientific article published on 21 September 2016
Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.

scientific article
Glucose normalization and outcomes in patients with acute myocardial infarction

scientific article
Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

scientific article published in January 2005
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article published on 01 March 2016
Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy

scientific article published on 22 December 2006
Metformin and thiazolidinedione use in Medicare patients with heart failure

scientific article
Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

scientific article published in July 2005
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

scientific article published on 21 March 2019

Paulina is supported by:

About Paulina

Help